Thirteen shipments, not twelve months
The plan grid for each product offers four terms and, for the one we read, states the number of shipments, the one-time payment, and the saving against paying every four weeks. Dividing the stated total by the stated shipment count gives the per-shipment figure exactly.
We have stored these as figures that are not monthly, with the division written into each qualifier. That is the whole reason the field exists. A four-week cycle repeated through a year is thirteen charges; presenting the same number as a monthly rate quietly understates the year by one payment, and a comparison against a genuinely monthly seller would be wrong by that margin.
Twenty-six of the one hundred and fifty-eight sellers here carry at least one figure that is not a monthly rate.
The cards and the grid disagree
Above the grid sit two summary cards, one per drug, each printing a figure with a per-month suffix and an asterisk. Neither of those figures is derivable from the grid: not as the per-shipment rate, not as the four-week rate implied by the stated saving, and not as the total divided by twelve.
We have recorded the grid figures, because those carry a shipment count and a total, and put the card figures into the grid rows' qualifiers. This is the third seller in this batch whose own page states two prices for one product, and it is the commonest defect in the market.
What else is on the page
A microdose lane is priced for both molecules at the same figure, on a shorter term with its own shipment count and total. The page states that the consultation, the prescription, the medication and shipping are all in one price, and that the service is self-pay only with no insurance.
It does not say whether a membership fee applies, and it uses the word membership to describe one of its own plan options, which is not an answer. Sixty-four of the one hundred and fifty-eight sellers here leave the question unanswered.
The operating company opens its own privacy policy with its full legal name, a version number, an effective date and a street address, which is a better identity disclosure than most. No compounding pharmacy is named and no individual clinician is named. No service area is published.
Aquivia Health's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $179per 4-week shipment on the 52-week plan, thirteen shipments for a one-time payment of $2,327 ($2,327 divided by 13 is $179) — the plan ships every four weeks, so a year is thirteen shipments and not twelve; the summary card above the grid prints $149/mo for the same product, which no term in the grid produces | September 2026source |
| Tirzepatide (compounded) | $269per 4-week shipment on the 52-week plan, thirteen shipments for a one-time payment of $3,497 ($3,497 divided by 13 is $269); the summary card above the grid prints $179/mo for the same product | September 2026source |
| Semaglutide (compounded) | $169per 4-week shipment on the 12-week microdose plan, three shipments for a one-time payment of $507 | September 2026source |
| Tirzepatide (compounded) | $169per 4-week shipment on the 12-week microdose plan, three shipments for a one-time payment of $507 | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See Aquivia Health's current price →Good fit if
- Readers who want to see what a four-week billing cycle does to an advertised monthly price.
- Buyers who want the shipment count and the one-time total printed beside a plan.
- People who want a microdose lane priced separately for both molecules.
Look elsewhere if
- Anyone who needs one price per product. The summary cards and the plan grid state different figures for both drugs.
- Readers budgeting by calendar month; this seller bills by the four-week cycle.
- Buyers who want the compounding pharmacy or a clinician named, or a service-area list.
- People who need the membership question answered.
How this review was verified
- Re-read the pricing page and the privacy policy on 6 September 2026, comparing the requested path to the effective path and running a nonsense path against the host in the same run.
- Read the shipment count off the grid and did the division rather than accepting the per-month suffix on the summary cards, and wrote the division into each price qualifier.
- Recorded both the card figures and the grid figures rather than choosing between them.
- Marked every price row as not monthly, so no page on this site can print a monthly suffix beside a four-week figure.
- Screened the operating entity and the brand name against FDA's live warning-letter record with a known letter as a positive control and a nonsense string as a negative control in the same pass. Neither returned a letter. Untitled letters are published separately and were not searched.